Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-29
2011-03-29
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S278000
Reexamination Certificate
active
07915267
ABSTRACT:
The present invention provides a novel amide compound represented by the following formula, which has a matrix metalloproteinase inhibitory activity and is useful as a pharmaceutical agent.wherein each symbol is as defined in the specification.
REFERENCES:
patent: 2003/0078276 (2003-04-01), Andrianjara et al.
patent: 2005/0176741 (2005-08-01), Okano et al.
patent: 2004-529874 (2004-09-01), None
patent: 98/39329 (1998-09-01), None
patent: WO-03/091224 (2003-11-01), None
patent: WO-2005/105760 (2005-11-01), None
Joshi, Vidya, et al., “Synthesis of Some New 4-Quinazolinone-2-carboxy Esters, 2-Carboxamides, 2-Carboxyhydrazides & Their Tosyl Derivatives Having Potential Biological Activity,” Indian Journal of Chemistry, vol. 26B, 1987, pp. 602.604.
Reddy, V. Gopal, et al., “Synthesis of some new 2-azaheteryl and 2,3-azahetero-annelated quinazolinones,” Indian Journal of Chemistry, vol. 31B, 1992, pp. 764-767.
George, T., et al., “Synthesis of Substituted Quinazolines: Part II—Use of Diethyl Oxalate in Quinazoline Synthesis,” Indian Journal of Chemistry, vol. 9, 1971, pp. 1077-1080.
Myakushkene, G., et al., “Synthesis and Antimonoamineoxidase Activity of 1-(2-Quinazolonecarbonyl)-2-Arylmethyl-And(1-Arylethyl)Hydrazines,” Pharmaceutical Chemistry Journal, vol. 32, No. 10, 1998, pp. 521-523.
Reddy, P S N, et al., “Bisazaheterocycles: Part VIII—A new synthesis of 2, 2′-bisquinazolinones,” Indian Journal of Chemistry, vol. 41B, 2002, pp. 1950-1952.
Kontogiorgis, et al., “Matrix Metalloproteinase Inhibitors: A Review on Pharmacophore Mapping and (Q)Sars Results”, Current Medicinal Chemistry, 2005, 12, 339-355.
Kaieda Akira
Nara Hiroshi
Sato Kenjiro
Terauchi Jun
Edwards Angell Palmer & & Dodge LLP
Kim, Esq. Kongsik
McDowell Brian
Takeda Pharmaceutical Company Limited
Wilson James O
LandOfFree
Heterocyclic amide compound and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic amide compound and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic amide compound and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2772065